These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9863038)

  • 1. In vivo drug release behavior in dogs from a new colon-targeted delivery system.
    Ishibashi T; Hatano H; Kobayashi M; Mizobe M; Yoshino H
    J Control Release; 1999 Jan; 57(1):45-53. PubMed ID: 9863038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC).
    Ishibashi T; Ikegami K; Kubo H; Kobayashi M; Mizobe M; Yoshino H
    J Control Release; 1999 Jun; 59(3):361-76. PubMed ID: 10332066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting.
    Fukui E; Miyamura N; Uemura K; Kobayashi M
    Int J Pharm; 2000 Aug; 204(1-2):7-15. PubMed ID: 11011980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlations.
    Liu Y; Schwartz JB; Schnaare RL; Sugita ET
    Pharm Dev Technol; 2003; 8(4):409-17. PubMed ID: 14601965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
    Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
    J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-mechanistic drug release approach in a bead dosage form and in vivo predictions.
    Liu Y; Schwartz JB; Schnaare RL; Sugita ET
    Pharm Dev Technol; 2003; 8(4):419-30. PubMed ID: 14601966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
    Kadam VD; Gattani SG
    Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro and in vivo performance of a colonic delivery system.
    Ahmed IS; Ayres JW
    Int J Pharm; 2011 May; 409(1-2):169-77. PubMed ID: 21382462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery.
    Han M; Fang QL; Zhan HW; Luo T; Liang WQ; Gao JQ
    J Pharm Sci; 2009 Aug; 98(8):2626-35. PubMed ID: 19067397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
    Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
    J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
    Patel MM; Amin AF
    J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery.
    Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY
    Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-triggered colonic delivery: robustness of the polysaccharide approach in the fed state in man.
    Basit AW; Short MD; McConnell EL
    J Drug Target; 2009 Jan; 17(1):64-71. PubMed ID: 19016069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.